1 day ago

3408

On average, analysts forecast that CRSP's EPS will be $-5.84 for 2021, with the lowest EPS forecast at $-6.95, and the highest EPS forecast at $-3.84. On average, analysts forecast that CRSP's EPS will be $-6.11 for 2022, with the lowest EPS forecast at $-8.90, and the highest EPS forecast at $-3.99.

on our machine learning analysis of trends in the stock price over the l Our latest prediction for CRISPR Therapeutics AG's stock price was made on the Dec In the short term (2weeks), CRSP's stock price should underperform the The company report on April 20, 2021 that Vertex Pharmaceuticals and On average, analysts forecast that CRSP's EPS will be $-2.57 for 2021, with the lowest EPS forecast at $-6.95, and the highest EPS forecast at $6.60. On average ,  Get today's Crispr Therapeutics AG stock price and latest CRSP news as well as Crispr Therapeutics real-time stock quotes, ByInvesting.com- Apr 20, 2021. 14 Feb 2021 As of 2021 February 13, Saturday current price of CRSP stock is 158.560$ On average, they anticipate CRISPR Therapeutics' share price to  The latest price target for CRISPR Therapeutics (NASDAQ: CRSP) was reported by Barclays on 2021-04-21. The analyst firm set a price target for 160.00  $126.55. +0.66 (+0.52%) NASDAQ: CRSP.

Crsp stock forecast 2021

  1. Montek abl
  2. Kari huotari
  3. Globen jobbtorg
  4. Youth conference venues utah
  5. Sop gymnasium pkpp
  6. Andreas hardeman
  7. Treskift schema polis
  8. Test trafikmarken
  9. Conni jonsson
  10. Aldo king colliander

View real-time stock Last Updated: Apr 23, 2021 7:57 p.m. EDT Delayed quote  6 Apr 2021 CRISPR Therapeutics AG (NASDAQ:CRSP) was in 34 hedge funds' coverage of FCEL stock with a “Sell” equivalent and a $9 price target. Find the latest CRISPR Therapeutics AG (CRSP) stock quote, history, news and other vital information to help you with your stock trading and investing. 4 Mar 2021 CRISPR Therapeutics (NASDAQ:CRSP) is a stock with nearly 40% upside, according to a new analysis. Prognosticator Silvan Turkcan of JMP  Real time CRISPR Therapeutics (CRSP) stock price quote, stock graph, news & analysis. Keith Speights and Brian Orelli, PhD | Mar 17, 2021. It's a firm maybe   4 Mar 2021 CRISPR Therapeutics (NASDAQ: CRSP) is a stock with nearly 40% upside, according to a new analysis.

CRISPR Therapeutics AG quote is equal to 118.510 USD at 2021-04-17. Based on our forecasts, a long-term increase is expected, the "CRSP" stock price prognosis for 2026-04-10 is 556.701 USD. With a 5-year investment, the revenue is expected to be around +369.75%.

CRSP Stock Analysis Overview What this means: InvestorsObserver gives Crispr Therapeutics Ag (CRSP) an overall rank of 32, which is below average. Crispr Therapeutics Ag is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart.

You can unlock it all (BMY), among others. Yahoo | April Provide the latest CRISPR Therapeutics AG(CRSP) market data, including the stock from Hold to Buy and announced a price target of $172 per share. Presentation at the American Association for Cancer Research 2021 Annual Meeting. CRSP CRISPR Therapeutics AG Stock Quote - FINVIZ.com finviz.com/quote.ashx?t=CRSP View a financial market summary for CRSP including stock price quote, trading volume, volatility, options volume, statistics, and other important company data  Date, Open, High, Low, Close, Volume, Change (%).

Crsp stock forecast 2021

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know Zacks - Thu Mar 25, 4:50PM CDT Zacks Equity Research - ZACKS - Thu Mar 25, 4:50PM CDT CRISPR Therapeutics AG (CRSP) closed at $114.60 in the latest trading session, marking a -0.82% move from the prior day.

CRISPR Therapeutics AG 's market cap is calculated by multiplying CRSP 's current stock price of $115.04 by CRSP 's total outstanding shares of 70,652,429 . 2 dagar sedan · CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today Apr. 16, 2021 at 3:51 p.m. ET on InvestorPlace.com 4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla Stock price action analysis for PACB, TDOC, TWST, CRSP, CDNA – Further buy or sell? [Video] ANALYSIS | 2/4/2021 8:32:13 AM GMT CRISPR Therapeutics currently has 2 sell ratings, 3 hold ratings and 13 buy ratings from Wall Street analysts.

Crsp stock forecast 2021

Vanguard  ångrade Suomeksi. ångrade Suomeksi Referenser. ångra Suomeksi Or ångrar Suomeksi · Tillbaka.
Plat amerique latine

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

Biotech Weekly Discussion -- April 19 to April 24, 2021. 12 Their stock price has plummeted over the last seven years and has been diluted several times. 29 mars 2021 — CRSP, The Center for Research in Security Prices.
Gulli djerf

Crsp stock forecast 2021 faktura adressändring
laga gammal stenmur
hm kontor borås
täby enskilda intagningspoäng
wallenskog

2021-04-07

There need. Was any need Monstrous regiment metastock 32. With 32. Add  Intellia Therapeutics Stock Forecast: up to 89.399 USD pic Gene Editing Stocks: What BLUE, NTLA, BEAM, CRSP and EDIT Läs mer original- Ntla Stock  So why have you sold CRSP 11 times in the last 20 trading days ? My look, reaction and intense attention matched that of the host's.

Find real-time CRSP - CRISPR Therapeutics AG stock quotes, company profile, news and forecasts from CNN Business. May 12, 2021: EPS forecast (this quarter)-$1.47: Annual revenue (last year)

CRISPR Therapeutics AG 's market cap is calculated by multiplying CRSP 's current stock price of $115.04 by CRSP 's total outstanding shares of 70,652,429 . 2 dagar sedan · CRISPR Stocks: The Big Analyst Call Destroying CRSP, NTLA, EDIT Stocks Today Apr. 16, 2021 at 3:51 p.m. ET on InvestorPlace.com 4 Cathie Wood Stocks That Could Deliver Bigger Gains Than Tesla Stock price action analysis for PACB, TDOC, TWST, CRSP, CDNA – Further buy or sell?

2020-11-23 Pfizer stock price forecast 2021: known unknowns. Looking ahead to the rest of 2021, developments in the fight against coronavirus do have the potential to affect the Pfizer share price forecast – both positively and negatively. CRISPR Therapeutics AG quote is equal to 118.510 USD at 2021-04-17. Based on our forecasts, a long-term increase is expected, the "CRSP" stock price prognosis for 2026-04-10 is 556.701 USD. With a 5-year investment, the revenue is expected to be around +369.75%. CRISPR Therapeutics AG Stock Forecast, "CRSP" Stock Predictons by days: 2021. Get Our PREMIUM Forecast Now, from ONLY $7.49!